Skip to Content

Living with Alzheimer’s

ABC 17 Family shares personal connections to Alzheimer’s Disease ahead of Columbia Walk to End Alzheimer’s

COLUMBIA, Mo. (KMIZ) ABC 17 News Anchor Meghan Drakas is sharing her family’s experience with Alzheimer’s disease along with other members of the ABC 17 family, in the leadup to Columbia’s Walk to End Alzheimer’s on Saturday. My grandmother Barbara Early was born in 1938 in the suburbs of Philly. She was a mother, grandmother,

Continue Reading

Work continues toward Alzheimer’s treatments, prevention as more than 122,000 Missourians battle disease

EDITOR’S NOTE: The total money raised from last year’s Columbia Walk to End Alzheimer’s has been corrected. COLUMBIA, Mo. (KMIZ) The Alzheimer’s Association says more than 122,000 Missourians 65 years and older are battling Alzheimer’s Disease, which has been documented for nearly 120 years. In that time, multiple treatments have been approved by the U.S.

Continue Reading

Two bipartisan Alzheimer’s bills signed into law as nearly 7 million Americans battle the disease

COLUMBIA, Mo. (KMIZ) This month President Joe Biden signed two pieces of bipartisan legislation into law which aim to aid the fight against Alzheimer’s Disease. According to the Alzheimer’s Association nearly 7 million people across the U.S. are battling the disease and this number is only expected to grow. NAPA Reauthorization Act The NAPA Reauthorization

Continue Reading

Over 122,000 Missourians battling Alzheimer’s Disease and that number continues to grow

COLUMBIA, Mo. (KMIZ) According to the latest data from the Alzheimer’s Association, more than 122,000 Missourians 65 years and older are battling Alzheimer’s Disease. Across the country, nearly 7 million people are living with the disease. Almost two-thirds of those affected are women. “The mission of the Alzheimer’s Association is to raise funds and awareness

Continue Reading

Jefferson City Walk to End Alzheimer’s raises over $104,000

COLUMBIA, Mo. (KMIZ) The Jefferson City Walk to End Alzheimer’s raised over $104,000 Sunday. The Alzheimer’s Association’s mission is to end Alzheimer’s and all other dementia through research and maximizing support. According to the organization, 55 million people live with Alzheimer’s and other dementias worldwide. Alzheimer’s is the most common form of dementia among adults,

Continue Reading

After US approval, Japan OKs its first Alzheimer’s drug. Leqembi was developed by Eisai and Biogen

By MARI YAMAGUCHI Associated Press TOKYO (AP) — Japan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S. pharmaceutical companies. It’s the first drug for the treatment of the disease in a country with a rapidly aging population. Leqembi was developed by Japanese drugmaker Eisai and

Continue Reading

Second Alzheimer’s drug in pipeline can slow the disease by a few months but with safety risk

By LAURAN NEERGAARD AP Medical Writer WASHINGTON (AP) — Another experimental Alzheimer’s drug can modestly slow patients’ inevitable worsening — by about four to seven months, researchers reported Monday. Eli Lilly and Co. is seeking Food and Drug Administration approval of donanemab. If cleared, it would be only the second Alzheimer’s treatment convincingly shown to

Continue Reading
Skip to content